Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -93.5% | -741.7% | 0 / 3 | +72.9% | +0.05 pp | -0.65 pp | -0.5% | 2.05 | — | 1.913 | +72,9% | −0,1 | −102,0% | — | 57.70 | — |
| Pts | 0 | 0 | 0 | 12 | 8 | 4 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 8.000 (close price on 2026-10-19)EPS (TTM): −60,5
Financial charts
1.Revenue & growth
VND bn1.913Q2/26
1.Revenue & growth
VND bn1.913Q2/26
2.Profit & growth
VND bn0,54Q2/26
3.Profit mix (Penman)
VND bn-10,2Q2/26
4.Margins & cost structure
%1.4%Q2/26
5.Returns & cash cycle
% · days0.3%Q2/26
6.Earnings quality & cash
VND bn-299Q2/26
7.Asset structure
VND bn6.411Q2/26
8.Funding & debt health
VND bn · times6.411Q2/26
9.Revenue backlog
VND bn27,3Q2/26
10.Valuation
times · %-110,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %4Q2/26
Adjusted EPS growth, latest quarter
-93.5%
Average adjusted EPS growth, 3 quarters
-86.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26